estetrol estrogen medication naturally occurring steroid hormone used combination progestin combined birth control pills development various indications investigational uses include menopausal hormone therapy treat symptoms vaginal atrophy hot flashes bone loss treatment breast cancer prostate taken estetrol naturally occurring bioidentical estrogen agonist estrogen receptor biological target estrogens like endogenous due estrogenic activity estetrol antigonadotropic effects inhibit fertility suppress sex hormone production levels women estetrol differs various ways natural estrogens like estradiol synthetic estrogens like ethinylestradiol implications tolerability instance appears minimal estrogenic effects breasts estetrol interacts nuclear erα manner identical estrogens distinct observed selective estrogen receptor modulators estetrol first discovered basic research continued started studied well investigated potential medical use major interest possible medical estetrol mid latestage clinical development variety estetrol available combination drospirenone following formulations brand names indications minimal side effects observed estetrol men decreased libido nipple tenderness observed highdose mgday estetrol four medication poses risk endometrial hyperplasia endometrial cancer women similarly necessary combine estetrol progestogen women intact uteruses prevent safety estetrol alone women intact uterus currently estetrolcontaining birth control pills similarly estradiolcontaining birth control pills may lower risk venous thromboembolism vte ethinylestradiolcontaining birth control pills based studies however likely another decade required postmarketing epidemiological studies vte incidence birth control pills completed able confirm estetrol agonist estrogen receptors ers hence moderate affinity erα erβ ki values nm nm estetrol preference erα comparison potent nonsteroidal estrogen diethylstilbestrol showed higher affinities ers ki values nm erα nm similarly estetrol low affinity ers relative estradiol thus estetrol related estrogen estriol require substantially higher concentrations estradiol produce similar affinity estetrol ers rat human estradiol vivo potency animals women estetrol found approximately times less potent orally ethinylestradiol potent oral estrogen high oral potency estetrol women spite relatively low affinity ers related high metabolic stability favorable estetrol shows high selectivity showed occupation androgen progesterone glucocorticoid receptors high concentration addition estetrol showed affinity μm set receptors enzymes sole exception weak affinity receptor inhibition prazosin binding concentration due high selectivity ers estetrol anticipated low risk undesirable offtarget activity associated side furthermore estetrol showed inhibition major cytochrome enzymes high concentration μm unlike estradiol conversely estetrol moderately stimulated estradiol strongly stimulated ethinylestradiol moderately inhibited enzyme findings suggest estetrol low potential drug interactions including lower potential estradiol particularly estetrol potent estrogenic effects bone vagina uterus myometrium endometrium arteries certain areas brain like pituitary gland hypothalamus terms hot flash relief antigonadotropic effects ovulation comparable efficacy ethinylestradiol bone turnover hot flashes estradiol valerate vaginal addition estetrol stimulatory effects endometrium poses risk endometrial hyperplasia endometrial cancer similar conversely effects estetrol certain tissues breastmammary gland liver vascular tissue various brain areas differ weakly estrogenic even antiestrogenic effects occurring based mixed effects different tissues estetrol described unique natural estrogen demonstrating absence specific membrane receptor effects interaction erα different serms estetrol low estrogenic effect breastmammary gland administered combination estradiol antagonizes effects relative estradiol estetrol shows lower potency stimulating proliferation human breast epithelial cells vitro mouse mammary gland cells animal models estetrol shows antiestrogenic effects antagonizing stimulatory effects estradiol preventing tumor development dmba mammary tumor anticipated estetrol may cause minimal proliferation breast tissue may useful treatment breast estetrol relatively minimal effects liver contrast estradiol ethinylestradiol estetrol stimulate hepatic production shbg addition found produce minimal changes liver protein synthesis women relative ethinylestradiol including production sex hormonebinding globulin shbg corticosteroidbinding globulin cbg angiotensinogen agt ceruloplasmin cholesterol triglycerides estrogensensitive coagulation proteins insulinlike growth factor insulinlike growth factorbinding proteins clinical study mgday estetrol showed increase μgday ethinylestradiol shbg agt levels dosages oral contraceptive comparison reported dosage estradiol similar potency ethinylestradiol terms fshtooltip folliclestimulating hormone suppression hot flash relief possesses potency ethinylestradiol shbg increase potency ethinylestradiol agt estetrol shown minor effects hemostatic biomarkers including coagulation due minimal influence liver function estetrol expected lower risk venous thromboembolism vte serious rare adverse effect known estrogens undesirable side also oral estrogens like ethinylestradiol associated reduction lean body mass due suppression hepatic production may expected estetrol potent estrogenic effects brain terms relief hot flashes antigonadotropic effects ovulation however animal studies investigating effects estetrol levels allopregnanolone βendorphin various brain areas shown weak estrogenic effects given alone antiestrogenic effects presence estradiol suggesting estetrol may sermlike effects regions brain mediating weak estrogenic effects levels allopregnanolone βendorphin administered alone causing antiestrogenic effects presence estradiol estetrol mixed effects vascular system found estrogenic effects atheroma prevention arteries hence might expected beneficial effects atherosclerosis antiestrogenic effects estradiolinduced endothelial nitric oxide synthase activation acceleration endothelial administration single doses estetrol postmenopausal women strongly suppressed secretion luteinizing hormone lh folliclestimulating hormone fsh demonstrating potent antigonadotropic levels lh suppressed dose mg slightly suppressed dose mg profoundly suppressed dose mg maximum profound sustained inhibition fsh levels maximum postdose lasting week found mg dose estetrol doses antigonadotropic effects estetrol result inhibition ovulation hence involved hormonal contraceptive effects addition antigonadotropic effects estetrol cause suppression gonadal sex hormone healthy men mgday estetrol suppressed total testosterone levels estradiol levels measured day another study healthy men testosterone levels suppressed estetrol therapy mgday mgday mgday suppression testosterone levels primary basis use estetrol treatment prostate oral bioavailability estetrol rats relative subcutaneous high oral bioavailability estetrol contrast estradiol estrone estriol low range similar ethinylestradiol estetrol shows high linear relationship across oral doses mg humans shows low interindividual upon oral administration estetrol rapidly absorbed maximal levels blood occurring within dosage mgday estetrol peak levels estetrol pgml trough levels pgml high water solubility estetrol makes optimal passage barrier drug may expected effects central nervous accordance estetrol shows clear central effects alleviation hot flashes antigonadotropic effects terms plasma protein binding estetrol bound moderately albumin bound contrast estradiol binds shbg high affinity similar estriol ethinylestradiol low affinity due lack affinity shbg plasma distribution availability target tissues estetrol limited otherwise influenced estetrol metabolized slowly minimally transformed estrogens estradiol estrone related fact estetrol already endstage product phase estrogen metabolism medication conjugated via glucuronidation lesser extent via biological halflife estetrol hours range blood halflives estradiol estriol hours minutes respectively far shorter estetrol whereas biological halflife ethinylestradiol approximately hours similar enterohepatic recirculation may occur estetrol similarly steroidal estrogens although also reported estetrol seem enter enterohepatic estetrol excreted mostly completely urine virtually entirely form conjugates unconjugated accounting one study median range recovered urine primarily estetrol glucuronide median range lesser extent estetrol sulfate median range estetrol also known naturally occurring estrane steroid derivative estrin four hydroxyl groups basis abbreviation comparison estriol three hydroxyl groups estradiol two hydroxyl groups estrone one hydroxyl group one chemical syntheses estetrol estetrol discovered egon diczfalusy coworkers karolinska institute stockholm sweden via isolation urine pregnant basic research estetrol conducted established estetrol exclusively synthesized human fetal liver estetrol regarded weak estrogen hampered interest research virtually subsequently pantarhei bioscience restarted investigate estetrol using stateoftheart technologies sole reasoning estetrol must biological role function importance would produced high quantities fetus estetrol major interest potential clinical use development phase iii clinical development combination drospirenone hormonal contraception mid latestage clinical development variety including menopausal hormone therapy mht mithra pharmaceuticals advanced breast prostate cancer pantarhei oncology estetrol mg combination drospirenone mg approved use hormonal contraception pending approval countries estetrol generic name drug inntooltip international nonproprietary estetrol development use alone variety indications applications include menopausal hormone therapy among phase iii clinical development estetrol vasomotor symptoms genitourinary symptoms menopause initiated october june phase ii clinical trials breast cancer prostate cancercitation needed addition singledrug formulation estetrol developed combination progestin drospirenone hormonal contraception use birth control pill prevent pregnancy drospirenone potent antimineralocorticoid antiandrogen addition progestogen relation said progesteronelike medication clinical development program hormonal contraception estetroldrospirenone combination completed dossier review european medicines agency ema us food drug administration estetrol studied humans oral doses dosages mgday estetrol studied postmenopausal women found effective alleviation menopausal high single doses estetrol mg studied women found estetrol times less potent orally highly potent estrogen pregnancy estetrol levels increase high concentrations pgml average mother pgml average fetus measured via umbilical cord blood estetrol levels times higher fetal circulation maternal circulation consequence fact estetrol produced exclusively fetal production high amounts estetrol pregnancy suggests may reasonably safe compound estetrol shows minimal inhibition induction cytochrome addition estetrol undergoes minimal phase metabolism enzymes conjugated via glucuronidation lesser extent sulfation estetrol expected harbor low risk drug